Navigation Links
Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate
Date:5/26/2009

SAN FRANCISCO, May 26 /PRNewswire/ -- Vaxart, Inc., a biotechnology company focused on the development of oral vaccines, announced today that the company has created a candidate vaccine for H1N1 influenza (swine flu). On Saturday, May 23, Vaxart began testing for immune responses in animals, just 25 days after initiating the project. The company will compare performance of the research-grade H1N1 vaccine to its successful avian flu vaccine as a first step towards potential human clinical testing.

The company has also begun preparing source material suitable for production of human H1N1 vaccine; an initial batch could be produced by August. However, human testing may not begin until fall or later, due to the need for safety testing in animals.

"Our oral vaccine could provide an important tool for swine flu pandemic preparation, because of the speed with which it could be delivered to groups such as first-line medical personnel," said Sean Tucker, Ph.D., Vaxart vice president of research.

Currently, pandemic flu vaccines are prepared by a slow and inefficient process that requires about six months before the first large amounts of vaccine are available. This process depends on creating an engineered variant of the circulating pandemic influenza strain and growing it in eggs. An advantage of Vaxart's approach is that it does not require culturing the flu virus in eggs; company scientists make a new vaccine by inserting a small piece of DNA matching the pandemic strain into Vaxart's pre-constructed vector. Vaxart's vector grows quickly and reproducibly in cell culture using a standard process.

Vaxart vaccines are novel in several ways, including the fact that they can be taken orally (i.e., by swallowing a capsule). In addition, the product is stable enough to be distributed without refrigeration. In an emergency, an approved Vaxart vaccine could be supplied by mail, rather than risking the sprea
'/>"/>

SOURCE Vaxart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
2. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
3. Genzyme Begins Major Expansion of Boston Manufacturing Facility
4. Medical Services Begins Working With United States Companies for Distribution of Its Products
5. Phlo Affiliate Begins Roll Out to Metropolitan New York City Account Base
6. Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health
7. SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM)
8. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
9. Ohio Task Force Begins Mission of Creating a New 21st Century Industry
10. Thomson Scientific Begins Expansion of Web of Science
11. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc.,(OTC ... a growing developer and,producer of prescription drugs ... the People,s Republic of China ("PRC"), today ... a controlled operating entity of Lotus,appointed Mr. ... the Company,s,Over-the-Counter Drug division ("OTC Division"). , ...
(Date:12/10/2009)... (NASDAQ: MATK) announced today that it has entered into ... Fonterra Co-operative Group Limited for the use of Martek’s products ... pregnant and nursing mothers. , ... ... Corporation (NASDAQ: MATK) announced today that it has entered ...
(Date:12/10/2009)... Antibodies Produces First Candidates Which Selectively Target ... Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... results of a collaborative program between YM ... of Canada,s Biotechnology Research Institute (NRC-BRI). Utilizing ... to generate novel antibodies that target cell ...
(Date:12/10/2009)... in the country specifically established to treat adolescents and adults and ... the ACHDC has more than 3,000 patients in its registry. ... ... Foundation of Santa Monica has announced that total contributions now exceed ... support the Ahmanson/UCLA Adult Congenital Heart Disease Center (ACHDC). ...
Breaking Biology Technology:Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3
... webcast: , , What: Abbott,s exercise of its ... a subsidiary of Isis. Total acquisition price will be, ... December 17, 2008 at 8:30 a.m. ET / 5:30 a.m. PT, Where: ... Simply log onto our Web site listed, ...
... line with Jatropha World Asia 2009, scheduled 16-17 ... of interviews with top Jatropha decision makers have ... and answer session was held with Pradip Bhar, ... Magor Biofuel Limited. Offered by free download, this ...
... ... (PRWEB) December 17, 2008 -- Facilitating the entry of ... protocol analyzer, now updated to effortlessly examine not only the wireless ... modem, but also the interface between the device CPU and the ...
Other Biology Technology:Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 3Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 4Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 2Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 3
(Date:12/14/2009)... Pa., Dec. 14 MODA Technology Partners, ... (EM), utility and product testing for the Pharmaceutical ... 3.0, the company,s third generation mobile data acquisition ... organizations to further automate their regulated manufacturing processes. ... capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... may help to engineer plants that take advantage of ... finding could help to engineer crops that take advantage ... carbon dioxide they need for photosynthesis through microscopic breathing ... molecule of the gas gained, they lose hundreds of ... tighten to save water when CO 2 is ...
(Date:12/13/2009)... New Haven, Conn.A team led by Yale University ... in whole blood for the first time. Their ... online publication of Nature Nanotechnology , could ... of cancer and other diseases. , ... Professor of Engineering & Applied Science, and Tarek ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 5767 1Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 5767 2BioMarin to Present at the Oppenheimer Healthcare Conference 5764 1BioMarin to Present at the Oppenheimer Healthcare Conference 5764 2PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 1PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 2PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 3PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 4PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 5PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 6PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 7PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 8PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 9PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 10
... new strategy developed in the Neonatal and Infant Feeding ... infants and other newborns with severe swallowing difficulties learn ... appearing in the February issue of the Journal ... Children,s were able to help 15 out of 20 ...
... N.C. Duke University Medical System researchers have discovered ... provide a new approach for future smoking-cessation products. ... Oliveira-Maia, M.D., Ph.D., a postdoctoral fellow of the Duke ... explore both the peripheral taste pathways activated by nicotine, ...
... NEW YORK The Damon Runyon Cancer Research ... researcher John Rinn, PhD, has been awarded a 2009 ... made to early-career researchers who are using "novel approaches ... member of the faculty at the Broad Institute in ...
Other Biology News:Crib-side studies help struggling newborns go home without feeding tubes 2Crib-side studies help struggling newborns go home without feeding tubes 3Nicotine activates more than just the brain's pleasure pathways 2BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award 2
Recombinant Viral CCI/Fc Chimera, CF...
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
... precipitation offers major advantages over other RNA precipitation ... protein or carbohydrates. It is the method of ... synthesis from RNA preparations. Note, LiCl precipitation may ... isolations. If the RNA is to be used ...
... The SlowFade Light Antifade Kit is ... photobleaching seen with fluorescent dyes. This formulation ... fluorescein AMCA and Cascade Blue fluorophores that ... (S-2828). This kit is available with the ...
Biology Products: